A presentation at the CTRC-AACR San Antonio Breast Cancer Symposium, held Dec. 6-10, 2011, showed that breast cancer survivors who carry the BRCA1 or BRCA2 genetic mutation are at high risk for developing contralateral breast cancer, ie. a new primary tumor in the other breast. According to the data, certain women within this group of carriers are at an even greater risk, based on age at ...